BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36152139)

  • 1. Are there differences in outcomes by race among women with metastatic triple-negative breast cancer?
    Oppong BA; Rolle AA; Ndumele A; Li Y; Fisher JL; Bhattacharyya O; Adeyanju T; Paskett ED
    Breast Cancer Res Treat; 2022 Nov; 196(2):399-408. PubMed ID: 36152139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial disparities in treatment and outcomes between non-Hispanic Black and non-Hispanic White women with nonmetastatic inflammatory breast cancer.
    Carbajal-Ochoa WH; Johnson D; Alvarez A; Bernal AM; Anampa JD
    Breast Cancer Res Treat; 2023 Sep; 201(2):275-287. PubMed ID: 37442877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational Epidemiology: An Integrative Approach to Determine the Interplay Between Genetic Ancestry and Neighborhood Socioeconomic Status on Triple Negative Breast Cancer.
    Goel N; Yadegarynia S; Kwon D; Kesmodel SB; Harbour JW; Kobetz E; Merchant N; Rodriguez DA
    Ann Surg; 2022 Sep; 276(3):430-440. PubMed ID: 35758508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receipt of breast conservation over mastectomy in Black women- does breast cancer subtype matter?
    Oppong BA; Bhattacharyya O; Li Y; Obeng-Gyasi S; Sheppard VB
    J Natl Med Assoc; 2022 Jun; 114(3):298-307. PubMed ID: 35272849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial/Ethnic Disparities in Pathologic Complete Response and Overall Survival in Patients With Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy.
    Woriax HE; Thomas SM; Plichta JK; Rosenberger LH; Botty van den Bruele A; Chiba A; Hwang ES; DiNome ML
    J Clin Oncol; 2024 May; 42(14):1635-1645. PubMed ID: 38394476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High triple-negative breast cancer prevalence and aggressive prognostic factors in Barbadian women with breast cancer.
    Hercules SM; Hercules JC; Ansari A; Date SAJ; Skeete DHA; Smith Connell SP; Pond GR; Daniel JM
    Cancer; 2020 May; 126(10):2217-2224. PubMed ID: 32154924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival difference between non-Hispanic black and non-Hispanic white women with localized breast cancer: the impact of guideline-concordant therapy.
    Wu X; Richardson LC; Kahn AR; Fulton JP; Cress RD; Shen T; Wolf HJ; Bolick-Aldrich S; Chen VW
    J Natl Med Assoc; 2008 May; 100(5):490-8. PubMed ID: 18507201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of racial differences in clinical outcomes of breast cancer patients receiving neoadjuvant chemotherapy: a single academic center study.
    Sarma M; Perimbeti S; Nasir S; Attwood K; Kapoor A; O'Connor T; Early A; Levine EG; Takabe K; Kalinski P; Ambrosone C; Khoury T; Yao S; Gandhi S
    Breast Cancer Res Treat; 2022 Apr; 192(2):411-421. PubMed ID: 35000093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent trends in racial and regional disparities in cervical cancer incidence and mortality in United States.
    Yoo W; Kim S; Huh WK; Dilley S; Coughlin SS; Partridge EE; Chung Y; Dicks V; Lee JK; Bae S
    PLoS One; 2017; 12(2):e0172548. PubMed ID: 28234949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial inequities in second-line treatment and overall survival among patients with metastatic breast cancer.
    Whitaker KD; Wang X; Ascha M; Showalter TN; Lewin HG; Calip GS; Goldstein LJ
    Breast Cancer Res Treat; 2022 Nov; 196(1):163-173. PubMed ID: 36028783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations Between Neighborhood-Level Income and Triple-Negative Breast Cancer in a Majority-Minority Population.
    Hernandez AE; Westrick AC; Stoler J; Kesmodel SB; Pinheiro PS; Figueroa M; Kobetz EN; Rebbeck T; Goel N
    Ann Surg Oncol; 2024 Feb; 31(2):988-996. PubMed ID: 37978105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial Differences in Time to Breast Cancer Surgery and Overall Survival in the US Military Health System.
    Eaglehouse YL; Georg MW; Shriver CD; Zhu K
    JAMA Surg; 2019 Mar; 154(3):e185113. PubMed ID: 30673075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updated racial disparities in incidence, clinicopathological features and prognosis of hypopharyngeal squamous carcinoma in the United States.
    Liang Z; Wu M; Wang P; Quan H; Zhao J
    PLoS One; 2023; 18(3):e0282603. PubMed ID: 36928727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial disparities in uterine and ovarian carcinosarcoma: A population-based analysis of treatment and survival.
    Rojas C; Tian C; Powell MA; Chan JK; Bateman NW; Conrads TP; Rocconi RP; Jones NL; Shriver CD; Hamilton CA; Maxwell GL; Casablanca Y; Darcy KM
    Gynecol Oncol; 2020 Apr; 157(1):67-77. PubMed ID: 32029291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient Characteristics at Prostate Cancer Diagnosis in Different Races at an Academic Center Serving a Diverse Population.
    Suresh T; Sharma J; Goel S; Kovac E; Gao Q; Gartrell B
    Clin Genitourin Cancer; 2019 Apr; 17(2):139-144. PubMed ID: 30655076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Black/white differences in treatment and survival among women with stage IIIB-IV breast cancer at diagnosis: a US population-based study.
    Enewold L; Penn DC; Stevens JL; Harlan LC
    Cancer Causes Control; 2018 Jul; 29(7):657-665. PubMed ID: 29860614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial disparities in survival among women with endometrial cancer in an equal access system.
    Park AB; Darcy KM; Tian C; Casablanca Y; Schinkel JK; Enewold L; McGlynn KA; Shriver CD; Zhu K
    Gynecol Oncol; 2021 Oct; 163(1):125-129. PubMed ID: 34325938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Race differences in cardiovascular disease and breast cancer mortality among US women diagnosed with invasive breast cancer.
    Troeschel AN; Liu Y; Collin LJ; Bradshaw PT; Ward KC; Gogineni K; McCullough LE
    Int J Epidemiol; 2019 Dec; 48(6):1897-1905. PubMed ID: 31155644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in Breast Cancer Death With Adjuvant Chemotherapy Among US Women According to Race, Ethnicity, and the 21-Gene Recurrence Score.
    Huang HC; Calip GS; Weiss J; Simons Y; Gadi VK; Danciu OC; Rauscher GH; Hoskins KF
    J Natl Compr Canc Netw; 2024 Jan; 22(1D):e237077. PubMed ID: 38190799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Racial/Ethnic Differences in Treatment and Mortality Among Women With Triple-Negative Breast Cancer.
    Cho B; Han Y; Lian M; Colditz GA; Weber JD; Ma C; Liu Y
    JAMA Oncol; 2021 Jul; 7(7):1016-1023. PubMed ID: 33983438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.